BioCryst Pharmaceuticals's chart data is dated 2026-10-09. Recorded technical signals: MACD bullish cross. There are 4 published signal records.
BioCryst Pharmaceuticals last closed at $8.55 (+3.14%) on 2026-10-09. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -5.7×. Its overall grade ranks 10 of 738 stocks in Healthcare.
About this company
BioCryst Pharmaceuticals last closed at $8.55 (+3.14%) on 2026-10-09. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 10/738
Valuation grade B+
Related stocks
- AstraZenecaCompetitor
희귀질환·면역질환 영역에서 글로벌 대형 제약사로 경쟁 관계
- Takeda PharmaceuticalCompetitor
희귀질환 및 혈장유래·면역질환 치료제 시장에서 경쟁
- CSLCompetitor
유전성 혈관부종(HAE) 등 희귀질환 치료제 분야 경쟁사
About BioCryst Pharmaceuticals
- What technical signals does BioCryst Pharmaceuticals (BCRX) have?
- BioCryst Pharmaceuticals current technical signals: MACD bullish cross.
- Is BioCryst Pharmaceuticals a cup-and-handle pattern?
- No. BioCryst Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for BioCryst Pharmaceuticals?
- Market cap: $1.8B. Trailing 12 months PER: -5.7×. Latest quarter PBR: -4.84×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about BioCryst Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.